Signaling pathways
-
BA5105 PronethalolSummary: Pronethalol ((±)-Pronethalo) is a non-selective beta-adrenergic antagonist. - BA5106 HydroxybupropionSummary: Hydroxybupropion is the main active metabolite of Bupropion and is metabolized primarily by CYP2B6.
- BA5108 VibegronSummary: Vibegron (MK-4618) is a potent
- BA5109 BI-167107Summary: BI-167107 is a high affinity full agonist at beta2 adrenergic receptors.
- BA5110 LubabegronSummary: Lubabegron is a potent beta-adrenergic receptor modulator.
- BA5111 L-765314Summary: L-765314 is a potent, selective antagonist.
- BA5112 OlodaterolSummary: Olodaterol (BI1744) is a selective
- BA5113 BufuralolSummary: Bufuralol (Ro3-4787) is a potent, non-selective, orally active beta-adrenoceptor antagonist with partial agonist activity.
- BA5115 LevonordefrinSummary: Levonordefrin is a common alternative to levylephrine as a vasoconstrictor in dental local anesthetics and is typically used in concentrations up to five times higher.
- BA5116 BatefenterolSummary: Batefenterol (GSK961081; TD-5959) is a new receptor antagonist and -adrenergic receptor agonist; on hM2.